Ledger.Open graph →
SEC Form D · filed November 18, 2020

Liminal BioSciences Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LAVAL, Quebec, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Alek A. Krstajic · Laval, Quebec, CanadaDirectorNeil A. Klompas · Vancouver, British Columbia, CanadaDirectorGary J. Bridger · Laval, Quebec, CanadaDirectorBruce Pritchard · Cambridge, United KingdomExecMoira Daniels · Cambridge, United KingdomExecMarie Iskra · Laval, Quebec, CanadaExecMartin Leclerc · Laval, Quebec, CanadaExecMurielle Lortie · La Jolla, CAExecPatrick Sartore · Laval, Quebec, CanadaExecTimothy S. Wach · Laval, Quebec, CanadaDirectorEugene A. Siklos · Laval, Quebec, CanadaDirectorSimon G. Best · Laval, Quebec, CanadaDirectorBruce Pritchard · Cambridge, United KingdomExecMoira Daniels · Cambridge, United KingdomExecMarie Iskra · Laval, Quebec, CanadaExecMartin Leclerc · Laval, Quebec, CanadaExecMurielle Lortie · La Jolla, CAExecPatrick Sartore · Laval, Quebec, CanadaExecTimothy S. Wach · Laval, Quebec, CanadaDirectorEugene A. Siklos · Laval, Quebec, CanadaDirectorAlek A. Krstajic · Laval, Quebec, CanadaDirectorNeil A. Klompas · Vancouver, British Columbia, CanadaDirectorSimon G. Best · Laval, Quebec, CanadaDirectorGary J. Bridger · Laval, Quebec, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗